6/2/2021 | CVLM | Inphi reports no tenders under offer for 0.75% convertibles due 2021, 2025
|
5/3/2021 | CVLM | Inphi tenders for 0.75% convertibles due 2021, 2025 after acquisition
|
4/20/2021 | CVLM | Inphi’s 0.75% convertible notes due 2021, 2025 may be converted following acquisition
|
10/29/2020 | CV | Market Commentary: Arch Resources eyed; Caliber Home on deck; Inphi soars outright, drops dollar-neutral
|
5/21/2020 | CVLM | Inphi offers to exchange 1.125%, 0.75% convertibles for cash, stock
|
4/27/2020 | CVLM | Inphi completes exchange of 1.125% convertible notes for cash, stock
|
4/27/2020 | CV | Inphi greenshoe exercised, ups five-year convertibles to $506 million
|
4/22/2020 | CV | Market Commentary: American Eagle convertibles offering eyed; Inphi skyrockets on debut; Snap expands
|
4/22/2020 | CV | Market Commentary: Morning Commentary: American Eagle Outfitters convertibles offering eyed; Inphi upsizes
|
4/22/2020 | CV | New Issue: Inphi sells upsized $440 million five-year convertible notes to yield 0.75%, up 32.5%
|
4/21/2020 | CV | Market Commentary: Inphi convertible offering eyed; 2U below par on secondary debut; Cree holds onto gains
|
4/21/2020 | CVLM | Inphi offers to exchange 1.125% convertible notes for cash, stock
|
4/21/2020 | CV | Market Commentary: Morning Commentary: 2U below par on secondary debut; Inphi convertible offering eyed
|
4/21/2020 | CV | Inphi talks $330 million five-year convertible notes to yield 0.75%-1.25%, up 27.5%-32.5%
|
10/15/2019 | CV | Market Commentary: Tilray convertibles trade actively; oil and technology names in focus; U.S. Steel on tap
|
10/15/2019 | CV | Market Commentary: Morning Commentary: Convertibles trading opens thin; ON Semiconductor, NextEra active
|
8/26/2019 | CV | Market Commentary: Fortive active; Medicines pops on trial data; Tesla 2% notes slightly higher with stock
|
8/26/2019 | CV | Market Commentary: Morning Commentary: Tesla 2% notes edge higher with shares; Inphi convertibles steady
|
2/8/2018 | CV | Market Commentary: Tech convertibles active on volatility; Tesla firm dollar neutral; Inphi notes active
|
2/8/2018 | CV | Market Commentary: Morning Commentary: Tesla convertibles flat but active on earnings reports; Inphi active
|
4/13/2017 | CV | Market Commentary: Morning Commentary: Holiday weighs on convertible market activity; Inphi mixed; Ashford up
|
9/12/2016 | CV | Inphi greenshoe exercised, lifts 0.75% convertibles to $287.5 million
|
9/8/2016 | CV | Market Commentary: New Insulet in line to better on debut; old Insulet slips; Ctrip.com, Inphi remain firm
|
9/7/2016 | CV | Market Commentary: Ctrip.com trades a little over par despite lower shares; Inphi bond adds; Retrophin surges
|
9/7/2016 | CV | Market Commentary: Morning Commentary: New Ctrip.com trades a little over par; new Inphi convertibles add
|
9/7/2016 | CV | New Issue: Inphi prices upsized $250 million five-year convertibles to yield 0.75%, up 35%
|
9/6/2016 | CV | Market Commentary: Four U.S. deals launch post-holiday; three international deals surface; Navistar pops
|
9/6/2016 | CV | Inphi to price $200 million five-year convertibles at 0.75%-1.25%, up 32.5%-37.5%
|
5/17/2016 | CV | Market Commentary: Allegheny Technologies launches new deal; Pandora eyed after activist investors urge sales
|
12/8/2015 | CV | Inphi greenshoe raises 1.125% convertible note sale to $230 million
|
12/3/2015 | CV | Market Commentary: Teva contracts on swap; new Inphi adds 0.5 point; Pandora, Vitamin Shoppe deals look cheap
|
12/3/2015 | CV | Market Commentary: Morning Commentary: New Teva lags; Inphi trades better; Pandora, Vitamin Shoppe deals look cheap
|
12/3/2015 | CV | New Issue: Inphi prices upsized $200 million five-year convertibles to yield 1.125%, up 35%
|
12/2/2015 | CV | Market Commentary: Upsized Nuance edges up in trade; planned Inphi looks cheap; Teva on tap; Pandora launches
|
12/2/2015 | CV | Market Commentary: Morning Commentary: New, upsized Nuance Communications edges up from par; planned Inphi looks cheap
|
12/1/2015 | CV | Market Commentary: Planned Nuance convertibles slightly cheap; Teva deal timing accelerated; Inphi on tap
|
12/1/2015 | CV | Inphi to price $150 million five-year convertibles to yield 0.875%-1.375%, up 32.5%-37.5%
|